Craig Emmitt Cole, M.D., is a Hematologist at the Karmanos Cancer Institute of McLaren Greater Lansing, and Assistant Professor in the Division of Hematology and Oncology at Michigan State University.
Dr. Cole’s research interests include multiple myeloma, non-Hodgkin’s lymphoma, therapeutic apheresis, and myelodysplasia. He has published and presented his research at the American Society of Hematology and the American Society for Apheresis national meetings. He also has a commitment to patient empowerment and education working with several local and national patient advocacy associations.
Dr. Cole received his Bachelor of Science degree in physiology at Michigan State University and the College of Lyman Briggs, in East Lansing Michigan. Dr. Cole went on to receive his doctoral degree at the Ohio State University College of Medicine in Columbus, Ohio. He completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan Health System, Ann Arbor, Michigan. Dr. Cole subsequently had a post-fellowship laboratory research position at the Jerome Lipper Multiple Myeloma Center of Medicine at Dana-Farber Cancer Institute in Boston, Massachusetts.